Co-Diagnostics Inc. (CODX) Live Share Price, Invest From India

Co-Diagnostics Inc. Stock Performance

as on June 27, 2026 at 2:15 pm IST

Day's Low
Day's High
$3.01
Day's Price Range
$3.24
$3.06
1.63%
Downside
5.88%
Upside
52 Week's Low
52 Week's High
$1.26
52-Week Price Range
$46.50
$3.06
58.82%
Downside
1419.61%
Upside

Co-Diagnostics Inc. share price movements today

Previous Close: $3.05
Open: $3.05
Volume: 1.0M
Day's Low - High: $3.01 - $3.24
52 Week Low - High: $1.26 - $46.50

Co-Diagnostics Inc. Historical Returns

1 Month Return: -66.52 %
3 Month Return: + 50.99 %
1 Year Return: -61.91 %
3 Year Return: -90.84 %
5 Year Return: -98.81 %

Co-Diagnostics Inc. Stock Fundamentals & Key Indicators

Check Co-Diagnostics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.0M

EPS (TTM)

-13.5

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.31%

PE Ratio (TTM)

PEG Ratio

EBITDA

-30.9M

Revenue (TTM)

718.2K

Profit Margin

0.00%

Return On Equity TTM

-151.66%

Co-Diagnostics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Co-Diagnostics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Co-Diagnostics Inc.	SELL	$12.0M	-98.81%	NA	0.00%	NA
Stryker Corporation	BUY	$120.3B	20.19%	36.35	13.21%	1.11%
Edwards Lifesciences Corp	BUY	$51.6B	-13.37%	46.94	17.39%	NA
Medtronic plc	BUY	$102.6B	-35.55%	21.48	13.20%	3.52%
Abbott Laboratories	BUY	$157.6B	-17.28%	25.35	13.90%	2.7%

See all

Stock Returns calculator for Co-Diagnostics Inc. Stock including INR - Dollar returns

The Co-Diagnostics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Co-Diagnostics Inc. investment value today

Current value as on today

₹42,156

Returns

-₹57,844

(-57.84%)

Returns from Co-Diagnostics Inc. Stock

-₹61,798 (-61.8%)

Dollar Impact

₹3,954 (+3.95%)

Analyst Recommendation on Co-Diagnostics Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Co-Diagnostics Inc.. Average target price of $45

Co-Diagnostics Inc. Share Price Target

Get share price movements and forecasts by analysts on Co-Diagnostics Inc..

What analysts predicted

93.2%UPSIDE

Target Price

$45

Current Price

$3.06

Analyzed by

6 Analysts

Target

$45.00

Co-Diagnostics Inc. target price $45, a slight upside of 93.2% compared to current price of $3.06. According to 6 analysts rating.

Indian Investors' Interest in Co-Diagnostics Inc. Stock

Investment in Co-Diagnostics Inc. Shares on INDmoney has grown by 45.45% in the last 30 days, indicating increased investment activity.

Time period: May 29, 2026 to June 28, 2026

Change:45.45% versus previous 30 day period

Search interest for Co-Diagnostics Inc. Stock has increased by 145% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 29, 2026 to June 28, 2026

Change:145% versus previous 30 day period

Co-Diagnostics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	3	0	2	0	0	0	0	0	0	0
Gross Profit	0	0	2	0	0	0	0	0	0	0
Operating Income	-11	-10	-7	-10	-11	-8	-8	-7	-7	-9
EBITDA	-10	-8	-7	-9	-10	-7	-7	-6	-25	-8
Interest Expense	3	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-9	-7	-9	-11	-7	-7	-7	-26	-9
Income Tax Expense	3	0	0	0	0	0	0	-1	0	0
Net Income	-14	-9	-7	-9	-11	-7	-7	-5	-25	-9
Net Profit Margin	-412.82%	-3684.36%	-286.03%	-1512.37%	-7387.37%	-14983.53%	-4745.02%	-4049.27%	-9755.05%	-6262.27%

Co-Diagnostics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	0	0	0	74	97	34	6	3	0
Gross Profit	0	0	0	0	57	86	28	2	2	0
Operating Income	-1	-4	-6	-5	41	46	-26	-42	-40	-31
EBITDA	-1	-6	-6	-6	41	45	-10	-36	-36	-47
Interest Expense	0	0	0	0	0	0	14	-	-	-
Depreciation	-	0	0	0	0	0	1	1	1	1
Income Before Tax	-1	-6	-6	-6	42	45	-18	-38	-37	-48
Income Tax Expense	-	0	0	0	0	8	-4	-2	0	-1
Net Income	-1	-6	-6	-6	42	36	-14	-35	-37	-46
Net Profit Margin	0.00%	-90827.88%	-15714.27%	-2882.00%	56.98%	37.45%	-41.61%	-518.68%	-961.37%	-7533.62%

Co-Diagnostics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-9	-7	-9	-11	-7	-7	-5	-25	-9
Operating Cash Flow	-8	-5	-7	-8	-8	-8	-5	-6	-7
Investing Cash Flow	16	-4	4	0	7	17	2	0	0
Financing Cash Flow	-	-	-	0	0	0	4	6	4
Change in Cash	8	-9	-3	-7	-1	9	0	0	-3

Co-Diagnostics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-6	-6	-6	42	36	-14	-35	-37	-46
Operating Cash Flow	-3	-4	-5	28	41	6	-22	-29	-29
Investing Cash Flow	0	0	0	-5	4	-58	15	17	26
Financing Cash Flow	5	1	5	19	0	-14	-1	0	11
Change in Cash	2	-2	0	42	45	-65	-8	-11	8

Global Institutional Holdings in Co-Diagnostics Inc.

Funds	Holdings
Triton Wealth Management, PLLC	0.03%
HARBOUR INVESTMENTS, INC.	0%
State Street Corp	0%
Virtu Financial LLC	0.12%
QRG Capital Management, Inc.	0.05%

See all

Co-Diagnostics Inc. News & Key Events

Insights on Co-Diagnostics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -25.74M → -9.14M (in $), with an average increase of 181.7% per quarter
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp has given 16.1% return, outperforming this stock by 77.2%
NO EFFECT
Against Peers
In the last 3 years, Stryker Corporation has given 0.4% return, outperforming this stock by 91.1%
NEGATIVE IMPACT
Price Dip
In the last 1 month, CODX stock has moved down by -72.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 263.92K → 145.95K (in $), with an average decrease of 44.7% per quarter

About Co-Diagnostics Inc.

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.

Organisation	Co-Diagnostics Inc.
Headquarters	2401 S. Foothill Drive, Salt Lake City, UT, United States, 84109
Industry	Medical Devices
CEO	Mr. Dwight H. Egan
E-voting on shares	Click here to vote

Key Management of Co-Diagnostics Inc.

Name	Title
Mr. Andrew Benson	Head of Investor Relations
Mr. Dwight H. Egan	Chairman, CEO & President
Mr. Dan Bohrer CPA	Vice President of Finance & Accounting
Mr. David Nielsen	Chief Operating Officer
Mr. Christopher Thurston	Chief Technology Officer
Dr. Mayuranki Almaula Ph.D.	Senior Vice President of Overseas Operations & Strategic Alliances
Mr. Seth Egan	Chief Commercialization Officer
Mr. Richard David Abbott	President
Mr. Brian L. Brown CPA	CFO & Company Secretary

FAQs

What is Co-Diagnostics Inc. share price today?

Co-Diagnostics Inc. share price today is $3.06 as on June 27, 2026 at 8:45 am IST at the close of the market. Co-Diagnostics Inc. share today touched a day high of $3.24 and a low of $3.01.

What is the 52 week high and 52 week low for Co-Diagnostics Inc. share?

Co-Diagnostics Inc. share touched a 52 week high of $46.5 on October 27, 2025 and a 52 week low of $1.26 on May 15, 2026. Co-Diagnostics Inc. stock price today i.e. June 27, 2026 at 8:45 am IST is closed at $3.06,which is 93.42% down from its 52 week high and 142.86% up from its 52 week low.

What is Co-Diagnostics Inc.'s market capitalisation today?

Co-Diagnostics Inc. market capitalisation is $0.00T as on June 27, 2026 at 8:45 am IST.

How to invest in Co-Diagnostics Inc. Stock (CODX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Co-Diagnostics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Co-Diagnostics Inc. Shares that will get you 0.4902 shares as per Co-Diagnostics Inc. share price of $3.06 per share as on June 27, 2026 at 8:45 am IST.

What is the minimum amount required to buy Co-Diagnostics Inc. Stock (CODX) from India?

Indian investors can start investing in Co-Diagnostics Inc. (CODX) shares with as little as ₹94.3 or $1 (as of June 28, 2026 at 6:59 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Co-Diagnostics Inc. stock (as per the Rupee-Dollar exchange rate as on June 28, 2026 at 6:59 am IST). Based on Co-Diagnostics Inc. share’s latest price of $3.06 as on June 27, 2026 at 8:45 am IST, you will get 3.2680 shares of Co-Diagnostics Inc.. Learn more about fractional shares .

What are the returns that Co-Diagnostics Inc. has given to Indian investors in the last 5 years?

Co-Diagnostics Inc. stock has given -98.81% share price returns and 27.46% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?